{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-childhood/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"69eb6e91-b113-53eb-bd4e-6a2f49ca6593","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 0cf5f10a-113b-4be7-a071-7aa7c6235ca2 --><h2>Changes</h2><!-- end field 0cf5f10a-113b-4be7-a071-7aa7c6235ca2 -->","summary":null,"htmlStringContent":"<!-- begin item b5998647-cc3b-4f69-8539-90c825d1af41 --><!-- begin field 43f91525-dae7-4c9a-8937-23c80d2f6942 --><p><strong>November 2020 </strong>— minor update. A table has been updated with information about eligibility for the HPV vaccine.</p><p><strong>October 2020 </strong>— minor update. The routine immunization schedule has been updated to include pneumococcal conjugate vaccine (PCV) at 12 weeks and one year for children born after 1 January 2020 in line with the Public Health England document <em>Routine childhood immunisations</em>. Reference to the previous PCV immunization schedule for children born before this date has been removed. </p><p><strong>August 2020</strong> — minor update. The age range of children who should receive the live attenuated influenza vaccine LAIV (Fluenz Tetra) has been updated in line with the NHS England letter <em>The national flu immunisation programme 2020 to 2021 - update</em>.</p><p><strong>July 2020 </strong>— minor update. The scope of the topic has been updated to include children with underlying medical conditions, a table has been added with details of additional vaccinations required for people with underlying medical conditions and there has been some minor restructuring. </p><p><strong>June 2020 </strong>— minor update. Advice on missed doses of MenB in children aged 1-2 years has been clarified.</p><p><strong>May 2020 </strong>— minor update. There are now two potential variations in administering MenB vaccines. The vaccination schedule for children up to 1 year of age has been updated in line with the manufacturer's SPC.</p><p><strong>February 2020</strong> — minor update. The vaccination schedule for pneumococcal vaccine has been updated in line with the Public Health England letter <em>Changes to the infant pneumococcal conjugate vaccine schedule </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2019a</a>]. </p><p><strong>September 2019</strong> — minor update. The recommendations for scheduled immunizations have been updated in line with the NHS England letter <em>The national flu immunisation programme 2019/20</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">NHS England, 2019</a>], and the chapter <em>The UK immunisation schedule </em>in the Public Health England (PHE) document <em>Immunisation against infectious disease</em><em> </em><em>('Green Book')</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2019b</a>] to include HPV vaccination in all children aged 12-13 years and flu vaccination in children aged 2–10 years.</p><p><strong>February 2018</strong> — minor update. SPC added for Infanrix vaccine.</p><p><strong>July 2017 </strong>— minor update</p><ul><li>Reviewed and updated following the publication of the Public Health England (PHE) recommendations on the routine immunization schedule June 2017. PHE (2017)<em> Hexavalent combination vaccine: programme guidance</em>. <a href=\"http://www.gov.uk/\" data-hyperlink-id=\"53b4ba86-27fb-4ed0-aa5e-a8f7014cbdd1\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/hexavalent-combination-vaccine-programme-guidance\" data-hyperlink-id=\"69bd43c8-5ce0-4332-8e2b-a8f7014cbddf\">Free Full-text</a>]. </li><li>The following changes have been made in response to updated PHE recommendations on the routine childhood immunization schedule:<ul><li>From autumn 2017, all babies born on or after 1 August 2017 will become eligible for a hexavalent vaccine which includes hepatitis B (HepB) for their primary immunisations. This vaccine, called Infanrix hexa<sup>®</sup>, will replace the pentavalent infant vaccines Infanrix<sup>®</sup>-IPV+Hib and Pediacel<sup>®</sup>.</li><li>All babies born on or after 1st August 2017 will become eligible for the vaccine eight weeks after their birth. Infanrix hexa<sup>®</sup> vaccine is expected to be made available to order online through the ImmForm website (<a href=\"http://www.immform.dh.gov.uk/\" data-hyperlink-id=\"07a9e57a-67b1-4c9d-a805-a8f7014cbdfb\">www.immform.dh.gov.uk</a>) from 1st September 2017 and will be distributed by Movianto UK for use in the routine childhood primary immunisation schedule at 8, 12 and 16 weeks of age.</li><li>Infants born before 1st August 2017 should complete the course with pentavalent vaccine (Pediacel<sup>®</sup> or Infanrix-IPV+Hib<sup>®</sup>). Infanrix hexa® should only be given to babies born before 1st August if there is no locally held vaccine stock and no further Pediacel<sup>® </sup>or Infanrix-IPV+Hib<sup>®</sup> can be ordered through ImmForm. It should also be given if pentavalent vaccine is not readily available - vaccination should never be delayed in order to obtain the pentavalent vaccine.</li></ul></li></ul><p><strong>November 2016</strong> — minor update.</p><ul><li>Information about the availability of the Public Health England (PHE) leaflets <a href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/525375/MenC_flyer_for_parents_to_explain_the_schedule_change_May16.pdf\" data-hyperlink-id=\"f6a095aa-93ef-4519-81ae-a8f7014cbe17\">MenC vaccination programme</a> , <a href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/543379/9867_MMR_A5leaflet.pdf\" data-hyperlink-id=\"62cf52c1-bec3-485e-a179-a8f7014cbe3d\">MMR vaccination</a> and <a href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/545554/PHE_9909_MenACWY_leaflet.pdf\" aria-describedby=\"attachment-1675173-accessibility-help\" data-hyperlink-id=\"e4b273c9-ed22-43c9-8c01-a8f7014cbe4b\">Meningitis and septicaemia: information for new university entrants</a> have been added to this topic.</li><li>Clinical immunosuppression has been specifically highlighted as contraindication to the administration of live vaccines in response to a Medicines and Healthcare products Regulatory Agency (MHRA) Drug safety update <em>Live attenuated vaccines: avoid use in those who are clinically immunosuppressed </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">MHRA, 2016</a>]<em>.</em></li></ul><p><strong>May to July 2016</strong> — reviewed. A literature search was conducted in May 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. </p><ul><li>The following changes have been made in response to updated PHE recommendations on the routine childhood immunization schedule (July 2016):<ul><li>The meningococcal group B (MenB) vaccine has been included at 8 weeks, 16 weeks, and one year old.</li><li>The MenC vaccine previously given at 12 weeks of age has been removed from the schedule.</li><li>The influenza vaccination programme now covers children aged two to eight years old (including children in school years 1, 2, and 3).</li><li>The dosing schedule of human papillomavirus vaccine (Gardasil®) has been changed to two doses given 6 to 24 months apart for girls 12–13 years of age.</li><li>A dose of tetanus, diphtheria, and polio vaccine is recommended specifically at 14 years old (school year 9) rather than 13–18 years old.</li><li>The MenC vaccine previously given at 14 years of age has been replaced by MenACWY vaccine.</li><li>A MenACWY catch-up programme is currently underway for older adolescents and new starters at university up to the age of 25 years.</li></ul></li><li>Changes have been made to the sections on Missed doses and Unknown immunization history to reflect these amendments to the routine childhood immunization schedule and the updated PHE guidance on <em>Vaccination of individuals with uncertain or incomplete immunisation status </em>(July 2016)<em>.</em></li><li>Key structural changes to the topic include: <ul><li>Removal of the sections on how vaccination leads to immunity and types of vaccines. This information is available in chapter 1 of the PHE publication <em>Immunisation against Infectious Disease</em>, commonly referred to as the 'Green Book', available at <a href=\"https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book\" data-hyperlink-id=\"bb2322d9-bfcd-4bcf-b492-a8f7014cbe5d\">www.gov.uk</a>. </li><li>Removal of the scenario 'Childhood immunization programme' and addition of a summary table of the routine immunization schedule into the Background information section.</li></ul></li></ul><!-- end field 43f91525-dae7-4c9a-8937-23c80d2f6942 --><!-- end item b5998647-cc3b-4f69-8539-90c825d1af41 -->","topic":{"id":"141a79f8-bf34-5bd6-9d3e-4e2d2e1c98f3","topicId":"884b0998-c242-4b76-869c-7e1d7203ac34","topicName":"Immunizations - childhood","slug":"immunizations-childhood","lastRevised":"Last revised in November 2020","chapters":[{"id":"6ba54a01-de23-5846-8b4d-e24477c75832","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ca5ebce-3bb6-51f5-897f-9f02d913dd37","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"49b0da44-2af1-559a-aa3d-b7492cc9ee0d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"69eb6e91-b113-53eb-bd4e-6a2f49ca6593","slug":"changes","fullItemName":"Changes"},{"id":"0b393c87-257a-567c-b12f-c3d1f55b13aa","slug":"update","fullItemName":"Update"}]},{"id":"ea1bc6cb-f5cf-5581-8659-301af7d9fb67","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f586895e-7f2d-51ef-baa8-6a9a1e98695f","slug":"goals","fullItemName":"Goals"},{"id":"1420f7f8-09c4-58fa-8d52-9b4a3d2a8ddf","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"16ddc68d-be0a-56cd-b38a-9acdf13a0bfe","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"713a5cac-cd5d-58d0-8793-b453d244027d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a6ab4abc-1ddb-5864-9f72-3eb58c16089a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b3ef6d84-ce51-57df-ba8a-40fbd3b7ceee","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e9c4eca9-e338-5ae7-9ad6-cffd74ef6c52","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9a89a8f0-b573-5292-93a2-1ee7ba24d67e","slug":"the-routine-childhood-immunization-schedule","fullItemName":"The routine childhood immunization schedule"},{"id":"fffdcf61-8f20-593c-9fbc-a4de125dab35","slug":"childhood-immunization-programme-coverage","fullItemName":"Childhood immunization programme coverage"}]},{"id":"e9b881e0-0306-56fc-975a-71fc5731b73a","fullItemName":"Management","slug":"management","subChapters":[{"id":"75d2baa6-d689-537b-985d-3b2b1c30e8b3","slug":"children-up-to-1-year-of-age","fullItemName":"Scenario: Children up to 1 year of age"},{"id":"cb326e70-51cb-5b55-86a4-5d1f28fbcf08","slug":"children-1-2-years-of-age","fullItemName":"Scenario: Children 1-2 years of age"},{"id":"6b4cbafe-fdfb-583a-a3fe-7a96b10253c4","slug":"children-2-10-years-of-age","fullItemName":"Scenario: Children 2-10 years of age"},{"id":"88a19f4f-827e-5331-836f-99c46181a1f9","slug":"children-over-10-years-of-age","fullItemName":"Scenario: Children over 10 years of age"},{"id":"df573b46-28ae-516a-adde-90b8bc742b29","slug":"additional-immunizations","fullItemName":"Scenario: Additional immunizations"}]},{"id":"3a2ea091-53a4-51b4-8c1b-16bbc187300b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"39c5bd91-68df-5d37-bdf6-a3fbf4194d8b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e5eea053-f5bc-5745-955b-0200236a454a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"8546e676-a44d-5c1d-a1b9-5d571b466524","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6b8c8a42-fd07-546b-8ec8-59db2829b422","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"913a73f4-d332-5491-a242-fb9e5fed1e37","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8e7e3dc1-7bda-57e5-ba9b-f03e0049b730","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d5fbf31a-ca3a-5b16-86c7-90949cade220","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"49b0da44-2af1-559a-aa3d-b7492cc9ee0d","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"e653baec-4a8d-50cd-9a1b-6405a0014941","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 24473471-8936-417b-ac0e-5aad2b220045 --><h3>Previous changes</h3><!-- end field 24473471-8936-417b-ac0e-5aad2b220045 -->","summary":null,"htmlStringContent":"<!-- begin item 181593ce-5e7b-4eba-92d5-d7abac8995fe --><!-- begin field f08d69b6-7182-46e4-a1a1-a291ff55f006 --><p><strong>November 2014 </strong>— three minor updates:</p><ul><li>Update to the text regarding co-administration of the chickenpox vaccine and the measles mumps and rubella (MMR) vaccine in line with 'The Green Book', chapter 34: Varicella.</li><li>Update to the text regarding the dosing interval for the MMR vaccine for children under two years of age.</li><li>Minor typographical error corrected regarding the age of administration of the HPV vaccine.</li><li>Update to the dosing schedule for the HPV vaccine in children aged 15 years and older in line with 'The Green Book', chapter 18a: Human papillomavirus (HPV).</li></ul><p><strong>September 2014 </strong>— minor update to the influenza immunization schedule to include children aged two, three and four in line with 'The Green Book', chapter 11: <em>The UK immunisation schedule</em>.</p><p><strong>June 2014 </strong>— two minor updates:</p><ul><li>Influenza — the influenza vaccine has been added to the routine immunization schedule for children aged two and three years old on the 1st September 2013.</li><li>Meningitis — recommendations to vaccinate new entrants to university and to offer young adults under the age of 25 years (not entering university) have been added.</li></ul><p><strong>May 2014</strong> — two minor updates to the text have been made in line with government policy as discussed in <em>Immunisation against Infectious Disease</em> (the 'Green Book'), published by Public Health England:</p><ul><li>Infanrix®has been introduced alongside Pediacel as the infant primary vaccine.</li><li>From September 2014, the number of human papillomavirus (HPV — Gardasil®) vaccines has been reduced from a three- to two-dose course for adolescent girls.</li></ul><p><strong>February 2014 </strong>— minor update. Removed reference to Cervarix® vaccine as Gardasil® is the HPV vaccine of choice, as recommended by the Department of Health in <em>Immunisation against Infectious Disease</em> (the 'Green Book'), chapter 18a: <em>Human papillomavirus</em> (HPV).</p><p><strong>December 2013</strong> — minor update. Correction of minor typographical errors.</p><p><strong>May 2013</strong> — minor update. The text has been amended to reflect new guidance from Public Health England in <em>Immunisation against Infectious Disease</em> (the 'Green Book') regarding the addition of rotavirus vaccination for infants, and the changes to the MenC vaccination schedule.</p><p><strong>January 2013</strong> — minor update. Change to the text to reflect Department of Health advice in <em>Immunisation against Infectious Disease</em> (the 'Green Book'), chapter 8:<em> Vaccine safety and the management of adverse events following immunisation</em>, on the use of paracetamol and ibuprofen to prevent fever at the time of vaccination.</p><p><strong>November 2012</strong> — reviewed. A literature search was conducted in September 2012 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. Changes have been made to the recommendation on immunizing children against chickenpox.</p><p><strong>August 2012 </strong>— minor update. Text revised to reflect Department of Health recommendations in <em>Immunisation against Infectious Disease</em> (the 'Green Book'), chapter 18a:<em> Human papillomavirus (HPV)</em> to switch from Cervarix<sup>® </sup>to Gardasil<sup>® </sup>human papillomavirus (HPV) vaccine for the national immunization programme from September 2012.</p><p><strong>June 2012 </strong>— minor update. Minor typographical error corrected.</p><p><strong>November 2010 </strong>— minor update. A letter from the Chief Medical Officer included the Joint Committee on Vaccination and Immunization recommendations that, from October 2010, the vaccines currently given at 12 months (Hib/MenC) and 13 months of age (MMR, PCV) should be given at the same visit, between 12 and 13 months of age, to simplify the routine childhood immunization schedule. Issued in November 2010.</p><p><strong>October 2010 </strong>— technical update. The management section of this topic has been simplified to improve clarity and navigation. There have been no changes to the clinical content or meaning of the recommendations.</p><p><strong>March 2010 </strong>— minor update. Prevenar<sup>® </sup>has been replaced by Prevenar 13<sup>®</sup>. Issued in March 2010.</p><p><strong>May 2009 </strong>— minor update. The Hib catch-up programme ceased on 3 March 2009. The pre-school booster has now reverted to DTaP/IPV (Infanrix-IPV<sup>®</sup>) or dTaP/IPV (Repevax<sup>®</sup>). This topic has been updated accordingly. Issued in June 2009.</p><p><strong>January 2009 </strong>— minor update. Information from the Rapid Response Report from the National Patient Safety Agency added, regarding the risks of omitting Hib when administering Infanrix-IPV+Hib<sup>®</sup>, if the powdered Hib component is not reconstituted using the contents of the pre-filled syringe. Issued in February 2009.</p><p><strong>November 2008 </strong>— minor update. Black triangle removed from Infanrix-IPV<sup>®</sup>, Infanrix-IPV+Hib<sup>®</sup>, Menitorix<sup>®</sup>, Pediacel<sup>®</sup>, and Repevax<sup>®</sup>. Issued in December 2008.</p><p><strong>October 2008 </strong>— minor update to clarify dosing schedule of human papillomavirus (HPV) vaccine. Issued in October 2008.</p><p><strong>September 2008 </strong>— minor update. New preparation of MMR vaccine, MMRVAXPRO<sup>® </sup>replaces MMR II<sup>®</sup>. A reference to the MMR catch-up programme 2008/2009 is also included based on <em>The MMR catch-up programme</em> from the Department of Health. Issued in September 2008.</p><p><strong>July 2008 </strong>— minor update. Black triangle status removed from Prevenar<sup>® </sup>vaccine. The introduction of the human papillomavirus vaccine into the national immunization programme to protect against the future risk of cervical cancer is summarized based on <em>Introduction of human papillomavirus vaccine into the national immunisation programme</em> from the Department of Health. Issued in August 2008.</p><p><strong>March 2008 </strong>— minor update. New text added regarding potential risk of apnoea in premature infants or those with a history of respiratory immaturity. Issued March 2008.</p><p><strong>October 2007 to February 2008 </strong>— converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There are no major changes to the recommendations. This topic has been updated from the guidelines published by the Department of Health, <em>Immunisation against infectious disease </em>(the 'Green Book').</p><p><strong>March 2007</strong>— minor update to include prescriptions for Infanrix-IPV+Hib vaccine. Issued in March 2007.</p><p><strong>October 2006 </strong>— minor update to include the new recommendations for the childhood immunization programme from the Chief Medical Officer. Issued in October 2006.</p><p><strong>November 2005 </strong>— minor update to include new information from the Senior Medical Officer regarding changes in the supply and administration of Tuberculin PPD for Mantoux testing. Issued in November 2005.</p><p><strong>July 2005 </strong>— updated to include new advice from the Chief Medical Officer on changes to the BCG vaccination programme. Minor updates also made to the text in the <em>Vaccinations procedures </em>and <em>Suitability for vaccination </em>sections. Information from <em>Medicines management </em>incorporated into <em>Complications and prognosis </em>and <em>What if the vaccination history is unknown or incomplete? </em>sections. Issued in July 2005.</p><p><strong>August 2004 </strong>— updated to include new vaccines and advice from the Joint Committee on Vaccination and Immunization. Validated in September 2004 and issued in September 2004.</p><p><strong>January 2004 </strong>— written. Validated in March 2004 and issued in June 2004.</p><!-- end field f08d69b6-7182-46e4-a1a1-a291ff55f006 --><!-- end item 181593ce-5e7b-4eba-92d5-d7abac8995fe -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}